Zomedica Pharmaceuticals Corp. to Present at LD Micro NYC Summit and Cantor 2018 Global Healthcare Conference
September 18 2018 - 5:55AM
Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V:ZOM)
(“Zomedica” or “Company”), a veterinary diagnostic and
pharmaceutical company, today announced that it will present at the
LD Micro NYC Summit on September 25 in New York, NY, and at the
Cantor Global Healthcare Conference on October 2 in New York, NY.
Chief Financial Officer Shameze Rampertab, CPA, CA, will provide
an overview of Zomedica’s business during his presentations and
will be available to participate in one-on-one meetings with
investors invited to attend each conference.
LD Micro NYC Summit
The LD Micro NYC Summit is an invite-only event. Interested
parties should contact david@ldmicro.com for further
information.
Cantor Global Healthcare Conference
Date: Tuesday, October 2, 2018Time: 4:35 p.m. ETLocation:
InterContinental New York Barclay Hotel, New York, NY
Webcast Information: Investors and other interested parties will
be able to access a live webcast of the presentation by visiting
Zomedica’s website
at http://www.zomedica.com/investor-information/events-presentations/.
A replay of the audio webcast and copies of the presentation will
be accessible on the Zomedica website following the event.
About ZomedicaBased in Ann Arbor, Michigan,
Zomedica (NYSE American:ZOM) (TSX-V:ZOM) is a veterinary diagnostic
and pharmaceutical company creating products for companion animals
(canine, feline and equine) by focusing on the unmet needs of
clinical veterinarians. Zomedica’s product portfolio will include
novel diagnostics and innovative therapeutics that emphasize
patient health and practice health. With a team that includes
clinical veterinary professionals, it is Zomedica’s mission to give
veterinarians the opportunity to lower costs, increase
productivity, and grow revenue while better serving the animals in
their care. For more information, visit www.ZOMEDICA.com.
Follow Zomedica
- Email Alerts: http://investors.zomedica.com
- LinkedIn: https://www.linkedin.com/company/zomedica
- Facebook: https://www.facebook.com/zomedica/
- Twitter: https://twitter.com/zomedica
Reader AdvisoryNeither TSX Venture Exchange nor
its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of the release.
Investor Relations ContactsShameze Rampertab,
CPA, CAsrampertab@zomedica.com+1 647.283.3630
PCG Advisory GroupKirin Smith, COOksmith@pcgadvisory.com+1
646.863.6519www.pcgadvisory.com
Media ContactAndrea
Eberleaeberle@zomedica.com+1 734.369.2555
Zomedica (AMEX:ZOM)
Historical Stock Chart
From Apr 2024 to May 2024
Zomedica (AMEX:ZOM)
Historical Stock Chart
From May 2023 to May 2024